Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
(2)
About
Gland Pharma Ltd.
NSE: GLAND
|
BSE: 543245
|
ISIN: INE068V01023
|
Industry: Pharmaceuticals
Policy Impact
|
Strong Performer, Getting Expensive
2178.7000
-34.40
(
-1.55
%)
NSE
Jun 16, 2026
15:31 PM
38.45% Gain from 52W Low
Volume:
509.8K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Gland Pharma Ltd.
07 Aug 2023
Policy Impact
2178.70
-1.55%
Healthy recovery in core markets
Buy:
Gland Pharma Ltd.
by
Motilal Oswal
Target: 1560
Target
Motilal Oswal
Gland Pharma has gained
30.48%
in the last 6 Months
More from Gland Pharma Ltd.
Recommended
Five stocks to buy from analysts this week - June 16, 2026
The Baseline |
16 Jun 2026, 05:11PM
Market closes higher on easing oil prices and foreign fund inflows
Trendlyne Marketwatch |
16 Jun 2026, 03:55PM
Gland Pharma IPO: A Chinese-owned pharmaceutical company hits the IPO market
|
12 Nov 2020